Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study

AIMS: Selective serotonin re-uptake inhibitors (SSRIs), specifically citalopram and escitalopram, are thought to cause QT(c) prolongation, although studies have shown contradictory results. Nevertheless, a maximum citalopram dosage of 20 mg in high risk patients (e.g. >60 years of age) is recomme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Maljuric, Nevena M, Noordam, Raymond, Aarts, Nikkie, Niemeijer, Maartje N, van den Berg, Marten E, Hofman, Albert, Kors, Jan A, Stricker, Bruno H, Visser, Loes E
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Drug Safety
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4594706/
https://ncbi.nlm.nih.gov/pubmed/25966843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12681
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados